Literature DB >> 23075320

Intracellular delivery and trafficking dynamics of a lymphoma-targeting antibody-polymer conjugate.

Geoffrey Y Berguig1, Anthony J Convertine, Julie Shi, Maria Corinna Palanca-Wessels, Craig L Duvall, Suzie H Pun, Oliver W Press, Patrick S Stayton.   

Abstract

Ratiometric fluorescence and cellular fractionation studies were employed to characterize the intracellular trafficking dynamics of antibody-poly(propylacrylic acid) (PPAA) conjugates in CD22+ RAMOS-AW cells. The HD39 monoclonal antibody (mAb) directs CD22-dependent, receptor-mediated uptake in human B-cell lymphoma cells, where it is rapidly trafficked to the lysosomal compartment. To characterize the intracellular-release dynamics of the polymer-mAb conjugates, HD39-streptavidin (HD39/SA) was dual-labeled with pH-insensitive Alexa Fluor 488 and pH-sensitive pHrodo fluorophores. The subcellular pH distribution of the HD39/SA-polymer conjugates was quantified as a function of time by live-cell fluorescence microscopy, and the average intracellular pH value experienced by the conjugates was also characterized as a function of time by flow cytometry. PPAA was shown to alter the intracellular trafficking kinetics strongly relative to HD39/SA alone or HD39/SA conjugates with a control polymer, poly(methacryclic acid) (PMAA). Subcellular trafficking studies revealed that after 6 h, only 11% of the HD39/SA-PPAA conjugates had been trafficked to acidic lysosomal compartments with values at or below pH 5.6. In contrast, the average intracellular pH of HD39/SA alone dropped from 6.7 ± 0.2 at 1 h to 5.6 ± 0.5 after 3 h and 4.7 ± 0.6 after 6 h. Conjugation of the control polymer PMAA to HD39/SA showed an average pH drop similar to that of HD39/SA. Subcellular fractionation studies with tritium-labeled HD39/SA demonstrated that after 6 h, 89% of HD39/SA was associated with endosomes (Rab5+) and lysosomes (Lamp2+), while 45% of HD39/SA-PPAA was translocated to the cytosol (lactate dehydrogenase+). These results demonstrate the endosomal-releasing properties of PPAA with antibody-polymer conjugates and detail their intracellular trafficking dynamics and subcellular compartmental distributions over time.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23075320      PMCID: PMC3600396          DOI: 10.1021/mp300338s

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  42 in total

1.  A robust method for the preparation and purification of antibody/streptavidin conjugates.

Authors:  M D Hylarides; R W Mallett; D L Meyer
Journal:  Bioconjug Chem       Date:  2001 May-Jun       Impact factor: 4.774

2.  A SPECTROPHOTOMETRIC ASSAY FOR AVIDIN AND BIOTIN BASED ON BINDING OF DYES BY AVIDIN.

Authors:  N M GREEN
Journal:  Biochem J       Date:  1965-03       Impact factor: 3.857

Review 3.  Arming antibodies: prospects and challenges for immunoconjugates.

Authors:  Anna M Wu; Peter D Senter
Journal:  Nat Biotechnol       Date:  2005-09       Impact factor: 54.908

4.  Analysis of cytosolic and lysosomal pH in apoptotic cells by flow cytometry.

Authors:  Cathrine Nilsson; Katarina Kågedal; Uno Johansson; Karin Ollinger
Journal:  Methods Cell Sci       Date:  2003

5.  Rapid acidification of endocytic vesicles containing alpha 2-macroglobulin.

Authors:  B Tycko; F R Maxfield
Journal:  Cell       Date:  1982-03       Impact factor: 41.582

6.  An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults.

Authors:  I T Magrath; C Janus; B K Edwards; R Spiegel; E S Jaffe; C W Berard; J Miliauskas; K Morris; R Barnwell
Journal:  Blood       Date:  1984-05       Impact factor: 22.113

7.  Anti-CD22 antibody targeting of pH-responsive micelles enhances small interfering RNA delivery and gene silencing in lymphoma cells.

Authors:  Maria C Palanca-Wessels; Anthony J Convertine; Richelle Cutler-Strom; Garrett C Booth; Fan Lee; Geoffrey Y Berguig; Patrick S Stayton; Oliver W Press
Journal:  Mol Ther       Date:  2011-05-31       Impact factor: 11.454

8.  Rational design of composition and activity correlations for pH-sensitive and glutathione-reactive polymer therapeutics.

Authors:  Mohamed E H El-Sayed; Allan S Hoffman; Patrick S Stayton
Journal:  J Control Release       Date:  2005-01-03       Impact factor: 9.776

9.  Intracellular delivery of a proapoptotic peptide via conjugation to a RAFT synthesized endosomolytic polymer.

Authors:  Craig L Duvall; Anthony J Convertine; Danielle S W Benoit; Allan S Hoffman; Patrick S Stayton
Journal:  Mol Pharm       Date:  2010-04-05       Impact factor: 4.939

10.  Cellular immunotherapy for follicular lymphoma using genetically modified CD20-specific CD8+ cytotoxic T lymphocytes.

Authors:  Jinjuan Wang; Oliver W Press; Catherine G Lindgren; Philip Greenberg; Stanley Riddell; Xiaojun Qian; Christian Laugen; Andrew Raubitschek; Stephen J Forman; Michael C Jensen
Journal:  Mol Ther       Date:  2004-04       Impact factor: 11.454

View more
  13 in total

1.  Three-dimensional localization of polymer nanoparticles in cells using ToF-SIMS.

Authors:  Daniel J Graham; John T Wilson; James J Lai; Patrick S Stayton; David G Castner
Journal:  Biointerphases       Date:  2015-06-03       Impact factor: 2.456

2.  Intracellular delivery system for antibody-Peptide drug conjugates.

Authors:  Geoffrey Y Berguig; Anthony J Convertine; Shani Frayo; Hanna B Kern; Erik Procko; Debashish Roy; Selvi Srinivasan; Daciana H Margineantu; Garrett Booth; Maria Corinna Palanca-Wessels; David Baker; David Hockenbery; Oliver W Press; Patrick S Stayton
Journal:  Mol Ther       Date:  2015-02-11       Impact factor: 11.454

3.  Gal8 Visualization of Endosome Disruption Predicts Carrier-Mediated Biologic Drug Intracellular Bioavailability.

Authors:  Kameron V Kilchrist; Somtochukwu C Dimobi; Meredith A Jackson; Brian C Evans; Thomas A Werfel; Eric A Dailing; Sean K Bedingfield; Isom B Kelly; Craig L Duvall
Journal:  ACS Nano       Date:  2019-01-18       Impact factor: 15.881

Review 4.  Drug discovery and therapeutic delivery for the treatment of B and T cell tumors.

Authors:  Regan Stephenson; Ankur Singh
Journal:  Adv Drug Deliv Rev       Date:  2017-06-15       Impact factor: 15.470

5.  Pairwise comparison of 89Zr- and 124I-labeled cG250 based on positron emission tomography imaging and nonlinear immunokinetic modeling: in vivo carbonic anhydrase IX receptor binding and internalization in mouse xenografts of clear-cell renal cell carcinoma.

Authors:  Sarah M Cheal; Blesida Punzalan; Michael G Doran; Michael J Evans; Joseph R Osborne; Jason S Lewis; Pat Zanzonico; Steven M Larson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-03-07       Impact factor: 9.236

Review 6.  Design of smart HPMA copolymer-based nanomedicines.

Authors:  Jiyuan Yang; Jindřich Kopeček
Journal:  J Control Release       Date:  2015-10-03       Impact factor: 9.776

7.  Mechanism of Enhanced Cellular Uptake and Cytosolic Retention of MK2 Inhibitory Peptide Nano-polyplexes.

Authors:  Kameron V Kilchrist; Brian C Evans; Colleen M Brophy; Craig L Duvall
Journal:  Cell Mol Bioeng       Date:  2016-06-06       Impact factor: 2.321

8.  Poly(propylacrylic acid)-peptide nanoplexes as a platform for enhancing the immunogenicity of neoantigen cancer vaccines.

Authors:  Feng Qiu; Kyle W Becker; Frances C Knight; Jessalyn J Baljon; Sema Sevimli; Daniel Shae; Pavlo Gilchuk; Sebastian Joyce; John T Wilson
Journal:  Biomaterials       Date:  2018-07-30       Impact factor: 12.479

9.  Lymphoma-targeted treatment using a folic acid-decorated vincristine-loaded drug delivery system.

Authors:  Lei Qiu; Chao Dong; Xuan Kan
Journal:  Drug Des Devel Ther       Date:  2018-04-17       Impact factor: 4.162

10.  A computationally designed inhibitor of an Epstein-Barr viral Bcl-2 protein induces apoptosis in infected cells.

Authors:  Erik Procko; Geoffrey Y Berguig; Betty W Shen; Yifan Song; Shani Frayo; Anthony J Convertine; Daciana Margineantu; Garrett Booth; Bruno E Correia; Yuanhua Cheng; William R Schief; David M Hockenbery; Oliver W Press; Barry L Stoddard; Patrick S Stayton; David Baker
Journal:  Cell       Date:  2014-06-19       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.